Nanostring technologies, INC.:1165300 [20-004297]
Ended Awarded
- Contract number
- 75N92B20F00002
- Awardee
-
Nanostring Technologies, Inc. UEI JEKKWSBFM2K4
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,568
Award facts
- Contract value 100% obligated
- $19,567.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339999 All Other Miscellaneous Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98119, USA
Award details come from SAM.gov/FPDS.
About this award
NanoString Technologies, Inc. received a $19,567.50 firm fixed-price BPA (Blanket Purchase Agreement) call from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health. The contract, awarded on September 5, 2020, with completion by September 30, 2020, was executed without a set-aside designation. Performance is based in Seattle, Washington. This award represents a task order under an existing BPA vehicle and aligns with NanoString's established role as a supplier of advanced genomic analysis platforms and life science tools to federal agencies, including the NIH enterprise.
NanoString Technologies is a publicly traded provider of specialized genomic analysis systems, including nCounter and GeoMx Digital Spatial Profiler platforms, along with associated reagents, assays, and consumables. The company maintains significant standing relationships with federal agencies across the NIH, Department of Defense, Department of Veterans Affairs, and USDA, supported by multiple indefinite delivery/indefinite quantity contracts and blanket purchase agreements valued in the millions of dollars. This NIAMS contract reflects continued federal investment in NanoString's capabilities to support biomedical research, molecular diagnostics, and translational research initiatives.
Quick answers
Who was awarded contract 75N92B20F00002?
75N92B20F00002 was awarded to Nanostring Technologies, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 5, 2020.
How much is contract 75N92B20F00002 worth?
The government has obligated $19,568 on 75N92B20F00002.
Is contract 75N92B20F00002 an order under another contract?
Yes. 75N92B20F00002 is a BPA call under HHSN263201400050B, a blanket purchase agreement.
Was contract 75N92B20F00002 competed?
The extent of competition for 75N92B20F00002 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award